{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T10:21:05Z","timestamp":1783333265472,"version":"3.54.6"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T00:00:00Z","timestamp":1783296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T00:00:00Z","timestamp":1783296000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virchows Arch"],"DOI":"10.1007\/s00428-026-04639-3","type":"journal-article","created":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T10:11:51Z","timestamp":1783332711000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Keratins and desmosomal proteins: Utility for molecular subtype identification in muscle-invasive bladder cancer"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-8097-6892","authenticated-orcid":false,"given":"Anna Katrin","family":"Scherping","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart\u0142omiej","family":"Tomasik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeton","family":"Luzha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Schostak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Burkhard","family":"Jandrig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Fehr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arndt","family":"Hartmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niklas","family":"Abele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Eckstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp","family":"Str\u00f6bel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcin","family":"Miszczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahrokh F.","family":"Shariat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michal","family":"Kunc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Garbers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"Czapiewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,6]]},"reference":[{"issue":"1","key":"4639_CR1","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1111\/his.13752","volume":"74","author":"A Lopez-Beltran","year":"2019","unstructured":"Lopez-Beltran A, Henriques V, Montironi R, Cimadamore A, Raspollini MR, Cheng L (2019) Variants and new entities of bladder cancer. Histopathology 74(1):77\u201396. https:\/\/doi.org\/10.1111\/his.13752","journal-title":"Histopathology"},{"issue":"1","key":"4639_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-018-22126-x","volume":"8","author":"NAD Marzouka","year":"2018","unstructured":"Marzouka NAD, Eriksson P, Rovira C, Liedberg F, Sj\u00f6dahl G, H\u00f6glund M (2018) A validation and extended description of the Lund taxonomy for urothelial carcinoma using the TCGA cohort. Sci Rep 8(1):1\u201312. https:\/\/doi.org\/10.1038\/s41598-018-22126-x","journal-title":"Sci Rep"},{"issue":"4","key":"4639_CR3","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/j.cell.2018.07.036","volume":"174","author":"AG Robertson","year":"2018","unstructured":"Robertson AG, Kim J, Al-Ahmadie H et al (2018) Comprehensive Molecular Characterization of Muscle-Invasive Bladder Cancer. Cell 174(4):1033. https:\/\/doi.org\/10.1016\/j.cell.2018.07.036","journal-title":"Cell"},{"issue":"8","key":"4639_CR4","doi-asserted-by":"publisher","first-page":"3110","DOI":"10.1073\/pnas.1318376111","volume":"111","author":"JS Damrauer","year":"2014","unstructured":"Damrauer JS, Hoadley KA, Chism DD et al (2014) Intrinsic subtypes of high-grade bladder cancer reflect the hallmarks of breast cancer biology. Proc Natl Acad Sci U S A 111(8):3110\u20133115. https:\/\/doi.org\/10.1073\/pnas.1318376111","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"4639_CR5","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.ccr.2014.01.009","volume":"25","author":"W Choi","year":"2014","unstructured":"Choi W, Porten S, Kim S et al (2014) Identification of Distinct Basal and Luminal Subtypes of Muscle-Invasive Bladder Cancer with Different Sensitivities to Frontline Chemotherapy. Cancer Cell 25(2):152\u2013165. https:\/\/doi.org\/10.1016\/j.ccr.2014.01.009","journal-title":"Cancer Cell"},{"issue":"4","key":"4639_CR6","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.eururo.2019.09.006","volume":"77","author":"A Kamoun","year":"2020","unstructured":"Kamoun A, de Reyni\u00e8s A, Allory Y et al (2020) A Consensus Molecular Classification of Muscle-invasive Bladder Cancer[Formula presented]. Eur Urol 77(4):420\u2013433. https:\/\/doi.org\/10.1016\/j.eururo.2019.09.006","journal-title":"Eur Urol"},{"issue":"1","key":"4639_CR7","doi-asserted-by":"publisher","first-page":"e32","DOI":"10.1097\/PAS.0000000000002053","volume":"48","author":"JI Warrick","year":"2024","unstructured":"Warrick JI, Al-Ahmadie H, Berman DM et al (2024) International society of urological pathology consensus conference on current issues in bladder cancer. Working group 4. Am J Surg Pathol 48(1):e32\u2013e42. https:\/\/doi.org\/10.1097\/PAS.0000000000002053","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"4639_CR8","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.ccr.2014.01.009","volume":"25","author":"W Choi","year":"2014","unstructured":"Choi W, Porten S, Kim S et al (2014) Identification of Distinct Basal and Luminal Subtypes of Muscle-Invasive Bladder Cancer with Different Sensitivities to Frontline Chemotherapy. Cancer Cell 25(2):152\u2013165. https:\/\/doi.org\/10.1016\/j.ccr.2014.01.009","journal-title":"Cancer Cell"},{"issue":"2","key":"4639_CR9","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1038\/onc.2010.456","volume":"30","author":"V Karantza","year":"2011","unstructured":"Karantza V (2011) Keratins in health and cancer: more than mere epithelial cell markers. Oncogene 30(2):127\u2013138. https:\/\/doi.org\/10.1038\/onc.2010.456","journal-title":"Oncogene"},{"issue":"6","key":"4639_CR10","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1007\/s00418-008-0435-6","volume":"129","author":"R Moll","year":"2008","unstructured":"Moll R, Divo M, Langbein L (2008) The human keratins: biology and pathology. Histochem Cell Biol 129(6):705\u2013733. https:\/\/doi.org\/10.1007\/s00418-008-0435-6","journal-title":"Histochem Cell Biol"},{"issue":"3","key":"4639_CR11","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1007\/s00441-015-2136-5","volume":"360","author":"JA Broussard","year":"2015","unstructured":"Broussard JA, Getsios S, Green KJ (2015) Desmosome regulation and signaling in disease. Cell Tissue Res 360(3):501\u2013512. https:\/\/doi.org\/10.1007\/s00441-015-2136-5","journal-title":"Cell Tissue Res"},{"key":"4639_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22115565","author":"UD Jerman","year":"2021","unstructured":"Jerman UD, Vi\u0161njar T, Bratkovi\u010d IH et al (2021) Attachment of cancer urothelial cells to the bladder epithelium occurs on uroplakin-negative cells and is mediated by desmosomal and not by classical cadherins. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms22115565","journal-title":"Int J Mol Sci"},{"key":"4639_CR13","doi-asserted-by":"publisher","first-page":"4059","DOI":"10.2147\/OTT.S136367","volume":"10","author":"G Zhou","year":"2017","unstructured":"Zhou G, Yang L, Gray A et al (2017) The role of desmosomes in carcinogenesis. Onco Targets Ther 10:4059\u20134063. https:\/\/doi.org\/10.2147\/OTT.S136367","journal-title":"Onco Targets Ther"},{"issue":"4","key":"4639_CR14","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1111\/j.1365-2559.2011.03988.x","volume":"59","author":"T Hayashi","year":"2011","unstructured":"Hayashi T, Sentani K, Oue N et al (2011) Desmocollin 2 is a new immunohistochemical marker indicative of squamous differentiation in urothelial carcinoma. Histopathology 59(4):710\u2013721. https:\/\/doi.org\/10.1111\/j.1365-2559.2011.03988.x","journal-title":"Histopathology"},{"issue":"2","key":"4639_CR15","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.humpath.2012.05.018","volume":"44","author":"C Gulmann","year":"2013","unstructured":"Gulmann C, Paner GP, Parakh RS et al (2013) Immunohistochemical profile to distinguish urothelial from squamous differentiation in carcinomas of urothelial tract. Hum Pathol 44(2):164\u2013172. https:\/\/doi.org\/10.1016\/j.humpath.2012.05.018","journal-title":"Hum Pathol"},{"issue":"2","key":"4639_CR16","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.lungcan.2013.07.016","volume":"82","author":"J Mazi\u00e8res","year":"2013","unstructured":"Mazi\u00e8res J, Brugger W, Cappuzzo F et al (2013) Evaluation of EGFR protein expression by immunohistochemistry using H-score and the magnification rule: re-analysis of the SATURN study. Lung Cancer 82(2):231\u2013237. https:\/\/doi.org\/10.1016\/j.lungcan.2013.07.016","journal-title":"Lung Cancer"},{"issue":"6","key":"4639_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0179602","volume":"12","author":"D Sikic","year":"2017","unstructured":"Sikic D, Keck B, Wach S et al (2017) Immunohistochemiocal subtyping using CK20 and CK5 can identify urothelial carcinomas of the upper urinary tract with a poor prognosis. PLoS ONE 12(6):1\u201313. https:\/\/doi.org\/10.1371\/journal.pone.0179602","journal-title":"PLoS ONE"},{"issue":"2","key":"4639_CR18","doi-asserted-by":"publisher","first-page":"374","DOI":"10.2144\/03342mt01","volume":"34","author":"AI Saeed","year":"2003","unstructured":"Saeed AI, Sharov V, White J et al (2003) TM4: a free, open-source system for microarray data management and analysis. Biotechniques 34(2):374\u2013378. https:\/\/doi.org\/10.2144\/03342mt01","journal-title":"Biotechniques"},{"key":"4639_CR19","unstructured":"R Core Team. R: A language and environment for statistical computing. R Found Stat Comput. 2021. https:\/\/www.r-project.org\/."},{"key":"4639_CR20","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-24277-4","volume-title":"Ggplot2: elegant graphics for data analysis","author":"H Wickham","year":"2016","unstructured":"Wickham H (2016) Ggplot2: elegant graphics for data analysis. Springer-Verlag, New York"},{"key":"4639_CR21","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19113396","author":"M Eckstein","year":"2018","unstructured":"Eckstein M, Wirtz RM, Gross-Weege M et al (2018) Mrna-expression of krt5 and krt20 defines distinct prognostic subgroups of muscle-invasive urothelial bladder cancer correlating with histological variants. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms19113396","journal-title":"Int J Mol Sci"},{"issue":"7","key":"4639_CR22","doi-asserted-by":"publisher","DOI":"10.6061\/clinics\/2021\/e2587","volume":"76","author":"JN Ravanini","year":"2021","unstructured":"Ravanini JN, Assato AK, Wakamatsu A, Alves VAF (2021) Combined use of immunohistochemical markers of basal and luminal subtypes in urothelial carcinoma of the bladder: association with clinicopathological features and outcomes. Clinics (Sao Paulo) 76(7):e2587. https:\/\/doi.org\/10.6061\/clinics\/2021\/e2587","journal-title":"Clinics (Sao Paulo)"},{"issue":"3","key":"4639_CR23","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/s00428-019-02618-5","volume":"475","author":"MDC Rodriguez Pena","year":"2019","unstructured":"Rodriguez Pena MDC, Chaux A, Eich ML et al (2019) Immunohistochemical assessment of basal and luminal markers in non-muscle invasive urothelial carcinoma of bladder. Virchows Arch 475(3):349\u2013356. https:\/\/doi.org\/10.1007\/s00428-019-02618-5","journal-title":"Virchows Arch"},{"issue":"3","key":"4639_CR24","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/s00428-017-2064-8","volume":"470","author":"J Breyer","year":"2017","unstructured":"Breyer J, Wirtz RM, Otto W et al (2017) In stage pT1 non-muscle-invasive bladder cancer (NMIBC), high KRT20 and low KRT5 mRNA expression identify the luminal subtype and predict recurrence and survival. Virchows Arch 470(3):267\u2013274. https:\/\/doi.org\/10.1007\/s00428-017-2064-8","journal-title":"Virchows Arch"},{"issue":"4","key":"4639_CR25","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.eururo.2023.03.020","volume":"85","author":"A Cox","year":"2024","unstructured":"Cox A, Kl\u00fcmper N, Stein J, Sikic D, Breyer J, Bolenz C, Roghmann F, Erben P, Wirtz RM, Wullich B, Ritter M, H\u00f6lzel M, Schwamborn K, Horn T, Gschwend J, Hartmann A, Weichert W, Erlmeier F, Eckstein M (2024) Molecular urothelial tumor cell subtypes remain stable during metastatic evolution. Eur Urol 85(4):328\u2013332. https:\/\/doi.org\/10.1016\/j.eururo.2023.03.020","journal-title":"Eur Urol"},{"issue":"2","key":"4639_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms22020628","volume":"22","author":"B Kim","year":"2021","unstructured":"Kim B, Jang I, Kim K et al (2021) Comprehensive gene expression analyses of immunohistochemically defined subgroups of muscle-invasive urinary bladder urothelial carcinoma. Int J Mol Sci 22(2):1\u201316. https:\/\/doi.org\/10.3390\/ijms22020628","journal-title":"Int J Mol Sci"},{"issue":"3","key":"4639_CR27","doi-asserted-by":"publisher","first-page":"227","DOI":"10.5114\/wo.2024.144215","volume":"28","author":"A Scherping","year":"2024","unstructured":"Scherping A, Schinlauer A, Czapiewski P, Garbers C (2024) Downregulation of the keratins CK13 and CK14 does not significantly affect cell viability of human urinary bladder carcinoma cells. Wspolczesna Onkol 28(3):227\u2013234. https:\/\/doi.org\/10.5114\/wo.2024.144215","journal-title":"Wspolczesna Onkol"},{"key":"4639_CR28","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0098786","author":"AG Barber","year":"2014","unstructured":"Barber AG, Castillo-Martin M, Bonal DM, Rybicki BA, Christiano AM, Cordon-Cardo C (2014) Characterization of desmoglein expression in the normal prostatic gland. Desmoglein 2 is an independent prognostic factor for aggressive prostate cancer. PLoS ONE. https:\/\/doi.org\/10.1371\/journal.pone.0098786","journal-title":"PLoS ONE"},{"issue":"2","key":"4639_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1101\/cshperspect.a002543","volume":"1","author":"E Delva","year":"2009","unstructured":"Delva E, Tucker DK, Kowalczyk AP (2009) The desmosome. Cold Spring Harb Perspect Biol 1(2):1\u201317. https:\/\/doi.org\/10.1101\/cshperspect.a002543","journal-title":"Cold Spring Harb Perspect Biol"}],"container-title":["Virchows Archiv"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-026-04639-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00428-026-04639-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-026-04639-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T10:12:05Z","timestamp":1783332725000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00428-026-04639-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,6]]},"references-count":29,"alternative-id":["4639"],"URL":"https:\/\/doi.org\/10.1007\/s00428-026-04639-3","relation":{},"ISSN":["0945-6317","1432-2307"],"issn-type":[{"value":"0945-6317","type":"print"},{"value":"1432-2307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,6]]},"assertion":[{"value":"16 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Institutional review boards of the medical faculty of the University of Erlangen (IRB 302_19Bc, 97_18Bc) and of the University of Magdeburg (IRB 87\/19) approved the study before starting data collection. In accordance with the 1964 Helsinki Declaration and its later amendments, formal written informed consent was not required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"The institution of Hartmann., Abele., and Eckstein conducts research for AstraZeneca, Roche, Janssen Cilag, NanoString Technologies, Biocartis, ZytoVision, Novartis, Cepheid, Mindpeak, MSD, Gilead, palleos healthcare, Owkin, and BioNTech. Abele has an advisory role and\/or received honoraria from Mindpeak and Siemens Healthineers.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}